Delivery Order SPE2DB24D1205-SPE2DB25FCYCT
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,128.54 contract is for the delivery of VALTOCO 15 MG NASAL SPRAYS, with a completion date of June 20, 2025. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 10 mg VALTOCO nasal sprays. The contract has a ceiling value of $2,259.24 and a performance period extending to July 10, 2025. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that has held a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical since 2026, enabling it to...
- This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,257.83 award is for the delivery of VALTOCO 5 MG NASAL SPRAYS, a prescription medication. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
- This is a $2,290.00 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of VALTOCO 10 MG NASAL SPRAYS. The contract has an ultimate completion date of June 10, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,133.48 firm-fixed-price delivery order is for the supply of VALTOCO 10 MG nasal sprays, a specialty medication. The contract has an ultimate completion date of October 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,568,072 units of the pharmaceutical product VALTOCO 10 MG NASAL SPRAYS. The contract has a ceiling value of $2,259.24 and a period of performance through April 30, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery...
- This is a $1,993.17 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VALTOCO 10 MG NASAL SPRAYS, with a performance period ending on July 9, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,018.28 firm fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of VALTOCO 10 MG NASAL SPRAYS, a critical care medication, with an ultimate completion date of August 22, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical to provide a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of VALTOCO 10 MG NASAL SPRAYS. The contract has a ceiling value of $2,566.09 and a period of performance through May 15, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corporation holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,126.10 firm fixed-price contract is for the delivery of VALTOCO 5 MG nasal sprays, with a completion date of May 19, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCYCTDelivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,401.21 contract is for the supply of 10 mg VALTOCO nasal sprays, with a performance period ending on July 1, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is issued under that larger IDC contract, allowing the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract does not have a set-aside designation, indicating open competition. As a critical supplier of medical and pharmaceutical products to federal agencies, AmerisourceBergen Drug Corp leverages its expertise to fulfill diverse procurement needs, including medications across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 6/30/25 |